ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Gold OA

Cancer & Metabolism

Acronym:cmet
•
Abbreviation (ISO):CANCER METAB
•
Identifier (ISSN):2049-3002(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
5.9↑ +0.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Cancer & Metabolism

WoS Q2
35685.0320205.4720215.1520225.92023620245.320255.92026
Annual Impact Factor Metric
Current (2026):5.9
Scopus SJR & Rank
N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data
H-Index (Hirsch Index)
N/A

papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
41articles/year
100% Gold OA•100% Original Research

Aims & Scope

Cancer & Metabolism welcomes studies on all aspects of the relationship between cancer and metabolism, including: -Molecular biology and genetics of cancer metabolism -Whole-body metabolism, including diabetes and obesity, in relation to cancer -Metabolomics in relation to cancer; -Metabolism-based imaging -Preclinical and clinical studies of metabolism-related cancer therapies.

Topics Covered (Recognized by AI)
Biology99%Genetics94.6%Medicine94%Chemistry91.7%Internal medicine91.1%Biochemistry89.8%Endocrinology71.7%Cancer65.1%Physics59.4%Organic chemistry57.8%Gene56.5%Cancer research54.9%Nuclear magnetic resonance53.7%Enzyme53%Cell biology51.7%Metabolism44.8%Cancer cell33.3%Pathology31.4%Glycolysis28.3%Bioinformatics27.9%Apoptosis23.8%Biotechnology22.5%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL BIOLOGY

Q2
Rank62/207
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q1
Rank65/333
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q2
Rank54/207
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank79/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.9
Articles / Year35
Total Citations7
2025
IF5.3
Articles / Year48
Total Citations226
2024
IF6
Articles / Year40
Total Citations425
2023
IF5.9
Articles / Year27
Total Citations469
2022
IF5.146
Articles / Year24
Total Citations743

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer & Metabolism (acronym: cmet, abbr: CANCER METAB, ISSN: 2049-3002) is a peer-reviewed international scholarly journal in the field of Multiple, published by BioMed Central in England since 2013. The periodical holds a Journal Impact Factor (JIF) of 5.90, ranking in quartile Q2 of Web of Science (SCIE).

The journal enforces rigorous peer evaluation with an annual output of approximately 41 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Periodic
Founding Year
2013
Indexing & Databases
SCIEDOAJPubMed
Editorial Address
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 0b63aaca-412b-4d8f-9050-eba57c9a432f
Database Updated: 2026-10-01